NCT07483684 2026-03-19A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based DrugsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 Not yet recruiting142 enrolled